Company intelligence / Profile preview

Biological Consulting Europe

Heidelberg, Baden-Württemberg, Germany

Ownership: Private
Development stage: Other

Overview

Biological Consulting Europe (BCE) is a specialized consultancy firm providing strategic and technical support to the biotechnology and pharmaceutical industries. The company focuses on regulatory affairs, quality management, and clinical development strategies for biological products, including advanced therapy medicinal products (ATMPs), vaccines, and recombinant proteins. BCE assists clients in navigating complex European regulatory frameworks, such as EMA submissions and GMP compliance, to accelerate the path from development to market. Their services cater to both emerging biotech startups and established global pharmaceutical entities seeking expertise in European market entry.

Industry: Consulting

Beyond the preview

Go deeper on Biological Consulting Europe.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biological Consulting Europe.

Explore the full profile